A review of litigation over random and “reasonable suspicion” drug testing. The scientific and technical issues in drug-testing arbitration disputes are explored.
- About Us
- Who We Are
- Presidents
- Committees and Coordinators
- Reports
- Regional Chairs and Boundaries
- Officials and Staff
- Honorary Life Members
- Constitution and By-Laws
- Fifty Years in the World of Work
- A Quarter Century of New Directions in Leadership and Mission
- Membership Guidelines
- Dues Policy
- Statement of Policy Relative to Membership
- Diversity Initiatives
- Non-Discrimination Policy
- Statement on Institutional Racism
- Arbitrator Development
- Professional Resources
- Presentations/Interviews
- Videoconferencing
- REF
- Meetings